| Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis among women with genitourinary infection and pregnancy-related complications in … M Rajabpour, AD Emamie, MR Pourmand, NN Goodarzi, FA Asbagh, ... International journal of STD & AIDS 31 (8), 773-780, 2020 | 21 | 2020 |
| Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals N Bolourchi, F Shahcheraghi, CG Giske, S Nematzadeh, ... Annals of Clinical Microbiology and Antimicrobials 20, 1-11, 2021 | 16 | 2021 |
| First Detection and Characterization of Macrolide-Resistant Mycoplasma pneumoniae from People with Community-Acquired Pneumonia in Iran N Noori Goodarzi, MR Pourmand, M Arfaatabar, G Azimi, E Masoorian, ... Microbial Drug Resistance 26 (3), 245-250, 2020 | 13 | 2020 |
| Identification of novel putative immunogenic targets and construction of a multi-epitope vaccine against multidrug-resistant Corynebacterium jeikeium using reverse vaccinology … S Shahbazi, S Sabzi, NN Goodarzi, S Fereshteh, N Bolourchi, B Mirzaie, ... Microbial Pathogenesis 164, 105425, 2022 | 12 | 2022 |
| Investigation of novel putative immunogenic targets against Staphylococcus aureus using a reverse vaccinology strategy NN Goodarzi, N Bolourchi, S Fereshteh, AS Shirazi, MR Pourmand, ... Infection, Genetics and Evolution 96, 105149, 2021 | 12 | 2021 |
| Construction of a chimeric FliC including epitopes of OmpA and OmpK36 as a multi-epitope vaccine against Klebsiella pneumonia NN Goodarzi, S Fereshteh, S Sabzi, S Shahbazi, F Badmasti Health Biothechnology and Biopharma 5, 44-60, 2021 | 12 | 2021 |
| Frequency of Mycoplasma pneumoniae, Legionella pneumophila and Chlamydia spp. among patients with atypical pneumonia in Tehran NN Goodarzi, MR Pourmand, M Rajabpour, M Arfaatabar, M Mosadegh, ... New microbes and new infections 37, 100744, 2020 | 12 | 2020 |
| Genome-Wide Subtraction Analysis and Reverse Vaccinology to Detect Novel Drug Targets and Potential Vaccine Candidates Against Ehrlichia chaffeensis S Sabzi, S Shahbazi, N Noori Goodarzi, F Haririzadeh Jouriani, M Habibi, ... Applied Biochemistry and Biotechnology 195 (1), 107-124, 2023 | 10 | 2023 |
| Reverse vaccinology approach to identify novel and immunogenic targets against Porphyromonas gingivalis: An in silico study O Nasiri, M Hajihassani, N Noori Goodarzi, S Fereshteh, N Bolourchi, ... Plos one 17 (8), e0273770, 2022 | 8 | 2022 |
| Comprehensive pan-genomic, resistome and virulome analysis of clinical OXA-48 producing carbapenem-resistant Serratia marcescens strains N Bolourchi, NN Goodarzi, CG Giske, S Nematzadeh, FH Jouriani, ... Gene 822, 146355, 2022 | 8 | 2022 |
| The combination of CipA and PBP-7/8 proteins contribute to the survival of C57BL/6 mice from sepsis of Acinetobacter baumannii F Badmasti, M Habibi, F Firoozeh, S Fereshteh, N Bolourchi, NN Goodarzi Microbial Pathogenesis 158, 105063, 2021 | 8 | 2021 |
| Rapid detection of Mycoplasma pneumoniae by loop-mediated isothermal amplification (LAMP) in clinical respiratory specimens M Arfaatabar, NN Goodarzi, D Afshar, H Memariani, G Azimi, E Masoorian, ... Iranian Journal of Public Health 48 (5), 917, 2019 | 8 | 2019 |
| In silico analyses of extracellular proteins of acinetobacter baumannii as immunogenic candidates S Fereshteh, NN Goodarzi, A Sepehr, M Shafiei, S Ajdary, F Badmasti Iranian Journal of Pharmaceutical Research: IJPR 21 (1), 2022 | 5 | 2022 |
| Determining host factors contributing to the reactivation of JC virus in kidney transplant recipients S Keykhosravi, M Khosravi, M Shenagari, E Hasan-Alizadeh, ... Virology Journal 19 (1), 131, 2022 | 5 | 2022 |
| Defeating a superbug: A breakthrough in vaccine design against multidrug-resistant Pseudomonas aeruginosa using reverse vaccinology S Fereshteh, F Haririzadeh Jouriani, N Noori Goodarzi, M Torkamaneh, ... PLoS One 18 (8), e0289609, 2023 | 3 | 2023 |
| Identification of Putative Drug Targets in Highly Resistant Gram-Negative Bacteria; and Drug Discovery Against Glycyl-tRNA Synthetase as a New Target S Fereshteh, N Noori Goodarzi, H Kalhor, H Rahimi, SM Barzi, F Badmasti Bioinformatics and Biology Insights 17, 11779322231152980, 2023 | 3 | 2023 |
| Subtractive genomic approach toward introduction of novel immunogenic targets against Clostridioides difficile: Thinking out of the box NN Goodarzi, S Fereshteh, O Azizi, H Rahimi, N Bolourchi, F Badmasti Microbial Pathogenesis 162, 105372, 2022 | 3 | 2022 |
| Introduction of novel putative immunogenic targets against Proteus mirabilis using a reverse vaccinology approach NN Goodarzi, N Bolourchi, S Fereshteh, F Badmasti Infection, Genetics and Evolution 95, 105045, 2021 | 3 | 2021 |
| In silico Evaluation, Cloning, and Expression of Omp22 as a Promising Vaccine Candidate against Acinetobacter baumannii S Sabzi, F Badmasti, N Noori Goodarzi, M Habibi, S Shahbazi, ... Vaccine Research 10 (1), 11-17, 2023 | 2 | 2023 |
| Subtractive genomic analysis for computational identification of putative immunogenic targets against clinical Enterobacter cloacae complex N Bolourchi, S Fereshteh, N Noori Goodarzi, F Badmasti Plos one 17 (10), e0275749, 2022 | 2 | 2022 |
Farzad BadmastiAssociate Professor of Bacteriology at Pasteur Institute of Iran在 pasteur.ac.ir 的电子邮件经过验证
